Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg
AFT Pharmaceuticals Ltd
Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)
23.75 mg
Modified release tablet
Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres
Prescription
Watson Pharma Private Limited
Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.
Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C
2016-06-24